Skip to main content

Table 4 Toxicities according to National Cancer Institute CTCAE (per patient)

From: Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

Toxicities Grade 1–2 Grade 3–4
  No. of Pts % No. of Pts %
Hematologic     
   Leucopenia 13 17.8 0 0.0
   Neutropenia 10 13.7 8 11.0
   Anemia 12 16.4 0 0.0
   Thrombocytopenia 5 6.8 1 1.4
Non-hematologic     
   Neuropathy 12 16.4 1 1.4
   AST/ALT abnormality 3 4.1 0 0.0
   Nausea 19 26.0 0 0.0
   Vomiting 9 12.4 0 0.0
   Mucositis 1 1.4 1 1.4
  1. AST, Aspartate aminotransferase; ALT, Alanine aminotransferase.